Summary:
The purpose of this trial is to evaluate the efficacy and safety of an investigational medication used for the treatment of moderate to severe plaque psoriasis.
The study would require you to complete 23 visits over a 15 month period.
Qualified Participants Must:
• Be 18 of age or older
•
Have moderate to severe plaque psoriasis
•
Have been unable to adequately control psoriasis with other therapies or treatments in the past
•
If female, not be pregnant or breastfeeding
•
Meet additional criteria that may apply
Qualified Participants May Receive:
By participating in the study, you will be compensated for time and travel expenses.